GPR55 and Parkinson disease: Next, we have investigated its neuroprotective profile in vitro (cell-based assays) and in vivo (neurotoxin-based models or genetically-modified mice) models of two neurodegenerative diseases, PD and ALS, in which the potential of GPR55 as a neuroprotective target has been claimed [32,51].